Analysts expect Virax Biolabs Group Ltd to report revenue of 1.50 M for 2023, against a range of 1.36 M to 1.63 M. The most recent reported year, 2025, came in at 12,423.00, a 67.6% miss against the 38,323.00 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | - | 6,331.00 | 12,423.00 | - |
| High Estimate | 214,510.32 | 1.63 M | 27,242.04 | 41,151.20 | 0.00 |
| Low Estimate | 201,409.68 | 1.36 M | 25,092.46 | 35,494.80 | 0.00 |
| Consensus Estimate | 207,960.00 | 1.50 M | 26,167.25 | 38,323.00 | 0.00 |
Analysts expect Virax Biolabs Group Ltd to report earnings per share of -44.21 for 2023, against a range of -47.60 to -40.82. The most recent reported year, 2025, came in at -13.70, a 45.0% miss against the -9.45 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Reported (Actual) | -127.50 | - | -40.62 | -13.70 | - |
| High Estimate | -83.92 | -40.82 | -37.85 | -8.88 | -6.07 |
| Low Estimate | -94.36 | -47.60 | -40.43 | -10.02 | -6.59 |
| Consensus Estimate | -89.14 | -44.21 | -39.14 | -9.45 | -6.33 |
Pull Wall Street consensus for Virax Biolabs Group Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VRAX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VRAX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VRAX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();